Gertz, R. J., Nikiforov, Y., Rehrauer, W., Mcdaniel, L., & Lloyd, R. V. (2016). Mutation inBRAFand Other Members of the MAPK Pathway in Papillary Thyroid Carcinoma in the Pediatric Population. Archives of Pathology & Laboratory Medicine, 140(2), 134-139. doi:10.5858/arpa.2014-0612-oa

Rush, P. S., Rosenbaum, J. N., Roy, M., Baus, R. M., Bennett, D. D., & Lloyd, R. V. (2017). Insulinoma-associated 1: A novel nuclear marker in Merkel cell carcinoma (cutaneous neuroendocrine carcinoma). Journal of Cutaneous Pathology. doi:10.1111/cup.13079

Mandal, R., Hardin, H., Baus, R., Rehrauer, W., & Lloyd, R. V. (2017). Analysis of miR-96 and miR-133a Expression in Gastrointestinal Neuroendocrine Neoplasms. Endocrine Pathology, 28(4), 345-350. doi:10.1007/s12022-017-9504-5

Yu, W., Denu, R. A., Krautkramer, K. A., Grindle, K. M., Yang, D. T., Asimakopoulos, F., Hematti, P., Denu, J. M. Loss of SIRT3 Provides Growth Advantage for B Cell Malignancies. The Journal of Biological Chemistry, 291(7), 3268–3279. (2016).

Denu, R. A., Zasadil, L. M., Kanugh, C., Laffin, J., Weaver, B. A., Burkard, M. E. Centrosome amplification induces high grade features and is prognostic of worse outcomes in breast cancer. BMC Cancer201616:47 DOI: 10.1186/s12885-016-2083-x (2016).

Bauman, T. M., Ricke, E. A., Drew, S. A., Huang, W., Ricke, W. A. Quantitation of Protein Expression and Co-localization Using Multiplexed Immuno-histochemical Staining and Multispectral Imaging. J. Vis. Exp. (110), e53837, doi:10.3791/53837 (2016).

Bauman TM, Ricke EA, Drew SA, Huang W, Ricke WA. Quantitation of Protein Expression and Co-localization Using Multiplexed Immuno-histochemical Staining and Multispectral Imaging. J Vis Exp. 2016 Apr 8;(110). PMCID: PMC4913774

Esbona K, Inman D, Saha S, Jeffery J, Schedin P, Wilke L, Keely P. COX-2 modulates mammary tumor progression in response to collagen density. Breast Cancer Res. 2016 Mar 22;18(1):35. PMCID: PMC4802888

Kuo PY, Leshchenko VV, Fazzari MJ, Perumal D, Gellen T, He T, Iqbal J, Baumgartner-Wennerholm S, Nygren L, Zhang F, Zhang W, Suh KS, Goy A, Yang DT, Chan WC, Kahl BS, Verma AK, Gascoyne RD, Kimby E, Sander B, Ye BH, Melnick AM, Parekh S. High-resolution chromatin immunoprecipitation (ChIP) sequencing reveals novel binding targets and prognostic role for SOX11 in mantle cell lymphoma. Oncogene. 2015 Mar 5;34(10):1231-40. PMCID: PMC4511176

Hope C, Ollar SJ, Heninger E, Hebron E, Jensen JL, Kim J, Maroulakou I, Miyamoto S, Leith C, Yang DT, Callander N, Hematti P, Chesi M, Bergsagel PL, Asimakopoulos F. TPL2 kinase regulates the inflammatory milieu of the myeloma niche. Blood. 2014 May 22;123(21):3305-15. PMCID: PMC4046426

Brand TM, Iida M, Dunn EF, Luthar N, Kostopoulos KT, Corrigan KL, Wleklinski MJ, Yang D, Wisinski KB, Salgia R, Wheeler DL. Nuclear epidermal growth factor receptor is a functional molecular target in triple-negative breast cancer. Mol Cancer Ther. 2014 May;13(5):1356-68. PMCID: PMC4013210

Wang L, Zhao Z, Meyer MB, Saha S, Yu M, Guo A, Wisinski KB, Huang W, Cai W, Pike JW, Yuan M, Ahlquist P, Xu W. CARM1 methylates chromatin remodeling factor BAF155 to enhance tumor progression and metastasis. Cancer Cell. 2014 Jan 13;25(1):21-36. PMCID: PMC4004525

Oberley MJ, Rajguru SA, Zhang C, Kim K, Shaw GR, Grindle KM, Kahl BS, Kanugh C, Laffin J, Yang DT. Immunohistochemical evaluation of MYC expression in mantle cell lymphoma. Histopathology. 2013 Oct;63(4):499-508. PMCID: PMC3871984

Nicholson TM, Sehgal PD, Drew SA, Huang W, Ricke WA. Sex steroid receptor expression and localization in benign prostatic hyperplasia varies with tissue compartment. Differentiation. 2013 Apr-Jun;85(4-5):140-9. PMCID: PMC3729928

Huang W, Hennrick K, Drew S. A colorful future of quantitative pathology: validation of Vectra technology using chromogenic multiplexed immunohistochemistry and prostate tissue microarrays. Hum Pathol. 2013 Jan;44(1):29-38. PMID: 22944297

Yang DT, Quann PJ, Petrich AM, Leith CP, Young KH, Kahl BS. Use of tissue microarray and automated quantitative analysis for screening and validation of potential biomarkers in mantle cell lymphoma. Appl Immunohistochem Mol Morphol. 2011 Jan;19(1):62-9. PMCID: PMC3040491

Leshchenko VV, Kuo PY, Shaknovich R, Yang DT, Gellen T, Petrich A, Yu Y, Remache Y, Weniger MA, Rafiq S, Suh KS, Goy A, Wilson W, Verma A, Braunschweig I, Muthusamy N, Kahl BS, Byrd JC, Wiestner A, Melnick A, Parekh S. Genomewide DNA methylation analysis reveals novel targets for drug development in mantle cell lymphoma. Blood. 2010 Aug 19;116(7):1025-34. PMCID: PMC2938124

Huang W, Kanehira K, Drew S, Pier T. Oncocytoma can be differentiated from its renal cell carcinoma mimics by a panel of markers: an automated tissue microarray study. Appl Immunohistochem Mol Morphol. 2009 Jan;17(1):12-7. PMID: 18769342